Institution
9 developments in the corpus
Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.
Latest
Everything in the corpus, newest first.
SEP 11, 2026 · INTERVENTIONAL STUDY
ClinicalTrials.gov
This is a terminated registry record with no results posted; it describes a small pilot study design without outcome data, suitable for hypothesis generation only.
This is a registry record for an actively recruiting observational cohort study with no posted results; it describes planned enrollment and data collection only.
SEP 3, 2026 · PHASE 2 TRIAL
ClinicalTrials.gov
This is an ongoing Phase 2 trial registration with no posted results; the study is recruiting and designed to evaluate safety, tolerability, and efficacy of zuranolone in a very small population (n=6) with post-stroke depression.
SEP 3, 2026 · PHASE 2 TRIAL
ClinicalTrials.gov
Phase 2 single-arm dietary supplement study with planned enrollment of 25 participants testing a novel ketone ester intervention in heart failure; no results are posted in this registry record.
This is a completed clinical trial registry record with no results posted; it describes the planned study design and outcomes but reports no efficacy or safety data.
AUG 7, 2026 · INTERVENTIONAL STUDY
ClinicalTrials.gov
This is a registry record for a planned feasibility and acceptability study with no results posted; enrollment has not yet begun.
This is a registry record of a planned interventional study with no results yet reported; enrollment is ongoing and primary outcomes are not yet measured.
This is an ongoing observational registry record with no results posted; it describes a planned blood collection study to characterize tarlatamab pharmacology in real-world SCLC treatment.